Wang Yi Fong

Title: Wang Yi Fong: Innovator in Enantioselective Synthesis

Introduction

Wang Yi Fong is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of biocatalysis and enantioselective synthesis. With a total of 2 patents, his work focuses on innovative processes that enhance the resolution of enantiomeric mixtures.

Latest Patents

Wang Yi Fong's latest patents include advancements in non-homogeneous systems for the resolution of enantiomeric mixtures. The first patent describes a process for the biocatalyst-mediated enantioselective conversion of hydrophobic esters using a biphasic solvent system. This invention particularly emphasizes the enzyme-mediated enantioselective synthesis of anti-viral compounds, such as 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane (FTC) and its analogues, in a non-homogenous reaction system. The second patent reiterates similar processes and applications, showcasing the importance of his research in the pharmaceutical field.

Career Highlights

Throughout his career, Wang Yi Fong has worked with prominent companies such as Gilead Sciences, Inc. and Altus Pharmaceuticals Inc. His experience in these organizations has allowed him to apply his innovative ideas in real-world applications, contributing to advancements in drug development and biocatalysis.

Collaborations

Wang Yi Fong has collaborated with notable professionals in his field, including Merrick R Almond and Yao Yiming. These collaborations have further enriched his research and development efforts, leading to impactful innovations.

Conclusion

Wang Yi Fong is a distinguished inventor whose work in enantioselective synthesis and biocatalysis has made a significant impact in the pharmaceutical industry. His patents reflect a commitment to advancing scientific knowledge and improving drug synthesis processes.